Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) announced a dividend on Wednesday, May 8th, NASDAQ reports. Investors of record on Monday, May 20th will be given a dividend of 0.0463 per share on Tuesday, May 28th. The ex-dividend date is Friday, May 17th.
Coloplast A/S Stock Performance
Shares of OTCMKTS:CLPBY opened at $12.21 on Thursday. The business has a 50-day simple moving average of $13.27 and a two-hundred day simple moving average of $12.12. The company has a debt-to-equity ratio of 0.76, a current ratio of 0.53 and a quick ratio of 0.35. Coloplast A/S has a fifty-two week low of $9.90 and a fifty-two week high of $14.45.
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) last issued its quarterly earnings data on Friday, February 9th. The company reported $0.08 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.08. Coloplast A/S had a net margin of 19.48% and a return on equity of 43.30%. The company had revenue of $953.60 million for the quarter. Equities research analysts forecast that Coloplast A/S will post 0.35 EPS for the current fiscal year.
About Coloplast A/S
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.
Read More
- Five stocks we like better than Coloplast A/S
- Investing in Travel Stocks Benefits
- Arm’s Earnings Stumble Could Create A Golden Entry Point
- The Most Important Warren Buffett Stock for Investors: His Own
- How to Bet on a Large Stock Price Move with an Options Strangle
- Buy P&G Now, Before It Sets A New All-Time High
- Shopify Stock Took a Breather, Markets Stay Bullish On its Future
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.